Search research articles
Contact Us
Filters
Showing results (11-20 of 139) with videos related to
Page
of 14
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 23, 2010
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling
Jorge J Palop, Lennart Mucke, Erik D Roberson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 13, 2023
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Shreya N Kashyap, Nicholas R Boyle, Erik D Roberson
Eneuro
|
September 12, 2015
Effects of Exercise on Progranulin Levels and Gliosis in Progranulin-Insufficient Mice
Andrew E Arrant, Aashka R Patel, Erik D Roberson
Brain Research Bulletin
|
December 17, 2013
The dendritic hypothesis for Alzheimer's disease pathophysiology
J Nicholas Cochran, Alicia M Hall, Erik D Roberson
Neurobiology of Aging
|
June 9, 2014
Seizure resistance without parkinsonism in aged mice after tau reduction
Zhiyong Li, Alicia M Hall, Mark Kelinske, et al.
Brain : a Journal of Neurology
|
November 25, 2015
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease
Ian F Kimbrough, Stefanie Robel, Erik D Roberson, et al.
Human Molecular Genetics
|
September 12, 2015
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity
J Nicholas Cochran, Travis Rush, Susan C Buckingham, et al.
The American Journal of Medicine
|
December 6, 2003
Polyneuropathy following gastric bypass surgery
Ken Nakamura, Erik D Roberson, Laura G Reilly, et al.
Epilepsy & Behavior : E&B
|
May 21, 2011
Geriatric epilepsy: research and clinical directions for the future
Erik D Roberson, Omotola A Hope, Roy C Martin, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2
Charles F Murchison, Richard E Kennedy, Jonathan E McConathy, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 139) with videos related to
Sort By:
Page
of 14
Methods in Molecular Biology (Clifton, N.J.)
|
October 23, 2010
Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling
Jorge J Palop, Lennart Mucke, Erik D Roberson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 13, 2023
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Shreya N Kashyap, Nicholas R Boyle, Erik D Roberson
Eneuro
|
September 12, 2015
Effects of Exercise on Progranulin Levels and Gliosis in Progranulin-Insufficient Mice
Andrew E Arrant, Aashka R Patel, Erik D Roberson
Brain Research Bulletin
|
December 17, 2013
The dendritic hypothesis for Alzheimer's disease pathophysiology
J Nicholas Cochran, Alicia M Hall, Erik D Roberson
Neurobiology of Aging
|
June 9, 2014
Seizure resistance without parkinsonism in aged mice after tau reduction
Zhiyong Li, Alicia M Hall, Mark Kelinske, et al.
Brain : a Journal of Neurology
|
November 25, 2015
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease
Ian F Kimbrough, Stefanie Robel, Erik D Roberson, et al.
Human Molecular Genetics
|
September 12, 2015
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity
J Nicholas Cochran, Travis Rush, Susan C Buckingham, et al.
The American Journal of Medicine
|
December 6, 2003
Polyneuropathy following gastric bypass surgery
Ken Nakamura, Erik D Roberson, Laura G Reilly, et al.
Epilepsy & Behavior : E&B
|
May 21, 2011
Geriatric epilepsy: research and clinical directions for the future
Erik D Roberson, Omotola A Hope, Roy C Martin, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2
Charles F Murchison, Richard E Kennedy, Jonathan E McConathy, et al.
Page
of 14